Mar 19, 2019
SMA Treatment Market Size Worth $3.9 Billion by 2025 | CAGR 12.9%: Grand View Research, Inc.
Feb 13, 2019
Ionis Pharmaceuticals to Hold 2018 Financial Results Webcast
Jan 02, 2019
Ionis Pharmaceuticals to Present at 37th Annual J.P. Morgan Healthcare Conference
Dec 20, 2018
Ionis Announces Plans for Management Transitions in 2020
Nov 19, 2018
Global Spinal Muscular Atrophy Treatment Market Outlook to 2023 - The Development of New Innovative Therapies is Propelling Demand
Nov 13, 2018
Ionis Pharmaceuticals to Present at Jefferies 2018 London Healthcare Conference
Nov 09, 2018
Ionis Pharmaceuticals to Host Investor Day
Nov 07, 2018
Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
Nov 06, 2018
Ionis Reports Third Quarter 2018 Financial Results
Oct 24, 2018
Ionis Pharmaceuticals to Hold Third Quarter 2018 Financial Results Webcast
Oct 23, 2018
Dr. C. Frank Bennett Receives Leslie Gehry Brenner Prize for Innovation in Science
Oct 17, 2018
Breakthrough Prize to CSHL professor for SMA research
Oct 10, 2018
Ionis Enters New Collaboration with Partner to Develop IONIS-FB-L Rx for Complement-Mediated Diseases
Aug 29, 2018
Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 07, 2018
Ionis Reports Second Quarter 2018 Financial Results
Aug 02, 2018
IONIS-HTT Rx (RG6042) Granted PRIME Designation by the European Medicines Agency for the Treatment of People with Huntington's Disease
Jul 24, 2018
Ionis Pharmaceuticals to Hold Second Quarter 2018 Financial Results Webcast
Jun 18, 2018
Ionis Pharmaceuticals Appoints Damien McDevitt as Chief Business Officer
Jun 05, 2018
Ionis Closes Strategic Collaboration with Biogen to Develop Drugs for a Broad Range of Neurological Diseases
May 23, 2018
Webcast Alert: Ionis Pharmaceuticals Provides Corporate Update at 2018 Annual Meeting of Stockholders